MFAT for Injuries: When Is It Recommended?

Abstract

Microfragmented adipose tissue, commonly called MFAT, is a regenerative treatment made from a small amount of a patient’s own fat tissue. It may be considered for moderate-to-severe joint damage, cartilage injuries, chronic tendon problems, and certain partial ligament or tendon tears. MFAT is usually considered when an injury is complex, slow to heal, or has not improved enough with chiropractic care, rehabilitation, physical therapy, or simpler regenerative injections such as platelet-rich plasma.

This article explains when MFAT may be recommended after a motor vehicle accident or workplace injury. It also compares MFAT with PRP and explains how ChiroMed’s integrated approach combines medical oversight, chiropractic care, functional medicine, personal injury services, and rehabilitation.

What Is MFAT?

Microfragmented adipose tissue is prepared from a small amount of the patient’s own fat tissue. Fat may be collected from the abdomen, lower back, side, or thigh through a small procedure called lipoaspiration.

The collected tissue is then:

• Cleaned
• Washed
• Mechanically processed into smaller sections
• Prepared for injection
• Placed into the injured joint or soft tissue

MFAT contains natural structural tissue, blood-vessel-related cells, signaling substances, and other components that may help support the injured area. It also provides a soft tissue framework that may help cushion damaged joints.

MFAT is different from laboratory-grown stem cell therapy. It is generally described as minimally processed tissue taken from the patient’s own body. University of Iowa Health Care lists MFAT as a nonsurgical option used for selected arthritic joints and tendon injuries (University of Iowa Health Care, n.d.).

When Is MFAT Recommended After an Injury?

MFAT is not normally the first treatment used after a car crash or workplace accident. Most patients begin with a careful examination, diagnostic imaging when needed, pain management, chiropractic care, rehabilitation, and activity changes.

MFAT may be considered when the injury is more severe, involves poor-quality tissue, or is not improving as expected.

Moderate-to-Severe Joint Damage

MFAT may be recommended when an accident causes significant damage inside a joint.

Examples may include:

• A knee striking the dashboard during a crash
• A worker falling directly onto the knee
• A twisting injury while lifting or carrying equipment
• Joint damage following a slip-and-fall accident
• Post-traumatic arthritis
• Worsening of arthritis that existed before the accident

A person may continue to experience swelling, stiffness, weakness, and difficulty walking even after completing conservative treatment.

The strongest clinical evidence for MFAT currently involves knee osteoarthritis. Research suggests that selected patients may experience improvements in pain and physical function. However, the available studies have limits, and the results should be interpreted with care (Hohmann et al., 2025; Li et al., 2023).

Cartilage Defects

Cartilage is the smooth material that covers the ends of bones inside a joint. It allows the joint to move with less friction.

A car accident or work injury may damage cartilage through:

• Direct impact
• Joint compression
• Sudden twisting
• Repeated loading
• Joint instability
• A bone or meniscus injury

Cartilage has a limited blood supply, which can make natural healing difficult. A patient with a cartilage defect may continue to experience catching, swelling, stiffness, or pain during weight-bearing activities.

MFAT may be discussed when imaging shows a moderate cartilage defect or post-traumatic joint degeneration. The goal is to support the joint environment and improve symptoms. It should not be described as a guaranteed way to regrow normal cartilage.

Larger Partial Tendon Tears

Tendons connect muscles to bones. A sudden collision, lifting injury, fall, or repetitive work activity may stretch or partially tear a tendon.

MFAT may be considered for selected conditions such as:

• Partial rotator cuff tears
• Chronic patellar tendon injuries
• Achilles tendon injuries
• Gluteal tendon damage
• Tennis elbow
• Chronic tendon degeneration
• Tendon problems that have not responded to rehabilitation

PRP is often considered first for mild or moderate tendon injuries. MFAT may be discussed when a tear is larger, the tissue quality is poor, or an earlier injection did not provide enough improvement.

Research involving MFAT for tendon injuries is less developed than research involving knee osteoarthritis. A careful examination and imaging review are needed before choosing this treatment. University of Iowa Health Care includes MFAT among the nonsurgical options it may use for selected tendon conditions, while also noting that surgery may still be required for severe tendon damage (University of Iowa Health Care, n.d.).

Partial Ligament Injuries

Ligaments connect one bone to another and help keep joints stable.

A motor vehicle or work-related accident may injure a ligament through:

• Sudden twisting
• Forceful joint movement
• Direct impact
• Hyperextension
• A fall onto an extended arm or leg

MFAT may sometimes be considered for a chronic partial ligament injury, especially when the surrounding tissue is damaged, and the patient has not responded to conservative care.

A complete ligament rupture or a joint that remains severely unstable may require surgical evaluation. Regenerative injections cannot physically reconnect every fully torn ligament.

Injuries That Have Not Improved With Conservative Care

One of the main reasons to consider MFAT is continued pain or loss of function after a reasonable period of conservative treatment.

Previous treatment may include:

• Chiropractic adjustments
• Physical rehabilitation
• Therapeutic exercise
• Soft-tissue therapy
• Bracing
• Activity modifications
• Medication when appropriate
• PRP injections
• A home exercise program

A lack of improvement does not automatically mean MFAT is needed. The care team must first confirm the source of the symptoms.

Continued pain could be caused by:

• An undiagnosed fracture
• A complete tendon tear
• Severe joint instability
• Nerve compression
• A spinal disc injury
• An infection
• Advanced arthritis
• Pain coming from another part of the body

The diagnosis should guide the treatment rather than selecting an injection based only on the location of pain.

MFAT Versus PRP

Platelet-rich plasma, or PRP, is made from a sample of the patient’s blood. The blood is processed to concentrate platelets and growth factors before being injected into the injured area.

PRP may be considered when the patient has:

• Mild-to-moderate joint degeneration
• Tendon irritation
• A smaller partial tendon tear
• A ligament sprain
• An injury with reasonable natural healing ability
• A condition that has not improved with basic conservative care

MFAT involves collecting and processing fat tissue. Because this requires a small lipoaspiration procedure, it is more involved than a regular blood draw.

MFAT may be discussed when there is:

• Moderate-to-severe joint degeneration
• A more significant cartilage defect
• Poor soft-tissue quality
• A larger chronic partial tear
• Continued symptoms after PRP
• A need for additional tissue cushioning or structural support

MFAT is not automatically better than PRP. A randomized clinical trial found that both MFAT and PRP improved patient-reported knee osteoarthritis symptoms, with no meaningful difference between the treatments after 12 months (Baria et al., 2024).

Another study also found that MFAT was not superior to PRP for knee osteoarthritis. Both treatments had similar failure and adverse-event rates (Zaffagnini et al., 2022).

These findings show why treatment must be selected based on the patient’s diagnosis, health, injury severity, and recovery goals.

Who May Not Be a Good MFAT Candidate?

MFAT is not appropriate for every personal injury patient. It is not a replacement for emergency treatment, orthopedic surgery, or neurological care.

MFAT may not be recommended when the patient has:

• An unstable fracture
• A complete tendon rupture
• A complete ligament tear
• Severe joint instability
• An active infection
• An open wound near the procedure area
• Progressive muscle weakness
• Severe spinal cord or nerve compression
• Advanced joint destruction
• A medical condition that increases procedure risks
• Unrealistic expectations about tissue regrowth

A patient taking blood thinners or living with diabetes, cardiovascular disease, immune problems, or another chronic condition may need additional medical review before receiving a procedure.

The U.S. Food and Drug Administration warns that regenerative medicine products have not been approved to treat orthopedic conditions such as osteoarthritis, tendonitis, back pain, knee pain, shoulder pain, or disc disease. Patients should ask what type of tissue is being used, how it is processed, and whether the treatment follows current regulatory requirements (U.S. Food and Drug Administration, 2021).

How Integrative Chiropractic Care Fits With MFAT

MFAT focuses on the biological side of an injury. It may help support the environment around damaged tissue, but it does not automatically correct poor movement, joint restriction, muscle weakness, or abnormal posture.

For example, a knee injection may not provide lasting improvement if the patient continues to place uneven pressure on the knee because of:

• Limited hip movement
• An unstable ankle
• Weak gluteal muscles
• Poor balance
• An abnormal walking pattern
• Spinal or pelvic restrictions

Chiropractic care and rehabilitation may address these mechanical problems.

At ChiroMed, an integrated recovery plan may include:

• Chiropractic adjustments
• Joint mobility care
• Soft-tissue treatment
• Corrective exercises
• Neuromuscular rehabilitation
• Balance and coordination training
• Posture correction
• Functional movement testing
• Nutrition support
• Medical evaluation
• Personal injury documentation

The goal is not to perform aggressive treatment directly over a newly treated area. Care should be properly timed so the tissue can settle before progressive movement and strengthening begin.

ChiroMed describes its integrated model as bringing together chiropractic care, medical oversight, functional medicine, rehabilitation, personal injury care, and regenerative options when clinically appropriate.

Treatment Timing After MFAT

The exact recovery plan depends on the area treated and the severity of the injury.

Before the Procedure

Before MFAT, the care team may examine:

• Joint movement
• Muscle strength
• Posture
• Balance
• Walking patterns
• Work activities
• Areas of compensation
• Previous treatment results

This creates a baseline for measuring progress.

Early Protection Phase

During the first stage, the patient should follow the procedure provider’s instructions. The injection and fat-collection areas may feel sore.

The patient may need to avoid:

• Heavy exercise
• High-impact activity
• Deep tissue pressure over the procedure area
• Aggressive joint manipulation
• Heavy lifting
• Repeated twisting
• Returning to full work duties too quickly

Gentle movement may be encouraged when it is medically appropriate.

Controlled Rehabilitation Phase

As discomfort improves, rehabilitation may include:

• Gentle range-of-motion exercises
• Light muscle activation
• Isometric exercises
• Balance training
• Controlled weight-bearing
• Low-resistance strengthening
• Walking or movement retraining

The exercises should increase gradually.

Return-to-Function Phase

The final stage may focus on:

• Lifting
• Carrying
• Driving
• Climbing stairs
• Returning to work
• Recreational exercise
• Sport-specific movements
• Preventing another injury

Progress should be based on the patient’s function and clinical findings rather than only the number of days since the injection.

ChiroMed’s Multidisciplinary Injury-Care Model

ChiroMed – Integrated Medicine in El Paso uses a multidisciplinary model that brings medical and musculoskeletal care together.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CCST, CFMP, IFMCP, ATN, provides an integrated clinical approach that includes:

• Chiropractic care
• Family nurse practitioner services
• Functional medicine
• Personal injury evaluation
• Musculoskeletal rehabilitation
• Clinical documentation
• Whole-body wellness planning

Dr. Maria Guadalupe Cardenas, MD, is board-certified in internal medicine and has more than 40 years of clinical experience. ChiroMed materials identify Dr. Cardenas as Medical Director and Collaborative Physician for Injury Medical Clinic PA. The clinic lists Texas Medical License #J2933 and NPI #1164426749.

Dr. Cardenas’s medical oversight may include reviewing:

• Chronic medical conditions
• Medications
• Laboratory results
• Procedure risks
• Cardiovascular concerns
• Diabetes or immune problems
• The need for specialist referrals

Dr. Jimenez focuses on the patient’s musculoskeletal injury, joint mechanics, spinal function, rehabilitation needs, and overall recovery plan.

This setup allows the team to coordinate:

• Internal medicine oversight
• Chiropractic treatment
• Functional medicine
• Regenerative care considerations
• Personal injury services
• Rehabilitation
• Nutrition and lifestyle support
• Diagnostic testing
• Referrals when needed

Dr. Jimenez’s Clinical Observations

Dr. Jimenez’s clinical observations emphasize that lasting injury recovery often requires more than reducing pain.

A successful plan may also need to address:

• Joint movement
• Muscle control
• Strength
• Stability
• Sleep
• Nutrition
• Inflammation
• Physical job demands
• Repeated movement patterns

He also stresses the importance of finding the real pain generator. Pain in one area may come from a joint, tendon, ligament, muscle, spinal disc, or irritated nerve.

For example, knee pain may be influenced by poor hip or ankle movement. Shoulder pain may be affected by the neck, upper back, or shoulder blade. Treating only the painful location may leave an important part of the injury unaddressed.

These clinical observations support individualized care but should not be viewed as a guarantee that every patient will respond to MFAT in the same way.

Final Thoughts

MFAT may be recommended after a motor vehicle accident or workplace injury when a patient has moderate-to-severe joint damage, a cartilage defect, chronic tendon degeneration, or a larger partial soft-tissue injury.

It may also be considered when chiropractic care, rehabilitation, physical therapy, or PRP has not provided enough improvement.

However, MFAT is not automatically better than PRP. It does not guarantee cartilage regrowth, and it cannot repair every complete tendon or ligament tear. The strongest evidence currently involves selected patients with knee osteoarthritis.

At ChiroMed, regenerative options may be considered as one part of a broader recovery plan. Medical oversight, chiropractic care, functional medicine, personal injury services, and progressive rehabilitation can work together to address both the biological and mechanical sides of an injury.

The right treatment begins with the right diagnosis.

---

References

Baria, M. R., et al. (2024). Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment. Orthopaedic Journal of Sports Medicine, 12(3).

ChiroMed. (n.d.-a). ChiroMed: Integrated medicine and holistic healthcare in El Paso, Texas.

ChiroMed. (n.d.-b). Integrative chiropractic and regenerative medicine.

ChiroMed. (n.d.-c). Regenerative medicine and chiropractic care in El Paso, Texas.

ChiroMed. (n.d.-d). Regenerative therapy for auto accident injury recovery.

Hohmann, E., et al. (2025). Microfragmented aspirated tissue injection therapy for symptomatic knee osteoarthritis: A systematic review of Level I to IV clinical studies.

Li, W., et al. (2023). Autologous microfragmented adipose tissue in the treatment of knee osteoarthritis: A systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 18.

University of Iowa Health Care. (n.d.-a). Microfragmented adipose tissue.

University of Iowa Health Care. (n.d.-b). Regenerative medicine.

U.S. Food and Drug Administration. (2021, June 3). Important patient and consumer information about regenerative medicine therapies.

Zaffagnini, S., et al. (2022). Microfragmented adipose tissue versus platelet-rich plasma for the treatment of knee osteoarthritis.